Develops and sells pharmaceuticals and medical devices
Photocure ASA develops and markets pharmaceuticals and medical devices based on proprietary photodynamic technology. It operates through the Cancer and Dermatology segments. The Cancer segment consists of the sale from Hexvix to pharmaceutical wholesalers in Nordic markets and Cysview in the United States. The Dermatology segment involves sale of MAL substance and the deferred recognition of Metvix revenue from Galderma. The company was founded on August 27, 1993 and is headquartered in Oslo, Norway.